Orasure Technologies market cap OSUR
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $284.8M
- Highest close in our data
- $1.3B
- Sep 2017
Orasure Technologies is worth $284.8M at the close on Oct 23, 2026, at $4.13 a share.
That is up 32% over the last year and down 63% over five years.
Its highest close in our data was $1.3B in Sep 2017.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $284.8M | $170.7M | $307.1M | +64% |
| 2025 | $173.6M | $162.8M | $299.9M | −36% |
| 2024 | $270M | $270M | $596.7M | −55% |
| 2023 | $602.6M | $331.1M | $609.2M | +72% |
| 2022 | $350M | $197.1M | $657M | −44% |
| 2021 | $626M | $597.9M | $1.1B | −18% |
| 2020 | $759.3M | $367.1M | $1.1B | +55% |
| 2019 | $488.9M | $407.4M | $801.8M | −30% |
| 2018 | $697.6M | $645M | $1.3B | −39% |
| 2017 | $1.1B | $475.4M | $1.3B | +134% |
| 2016 | $489.3M | $309M | $512.7M | +35% |
| 2015 | $363.7M | $256.4M | $578.5M | −37% |
| 2014 | $576.3M | $326.4M | $590.3M | +70% |
| 2013 | $338.1M | $215.5M | $402.9M | −8% |
| 2012 | $369.2M | $369.2M | $635.6M | −14% |
| 2011 | $430.2M | $302.8M | $452.8M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orasure Technologies' size, closest first, today.
| Company | Market cap |
|---|---|
| OSUROrasure Technologies | $284.8M |
| INFUInfuSystem | $277.6M |
| UTMDUtah Medical Products | $236.3M |
| EMBCEmbecta | $380.2M |
| PDEXPro DEX | $199.3M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| KEQUKewaunee Scientific | $94.9M |
| IRMDIradimed | $1.1B |
| STAAStaar Surgical | $1.1B |
| Peer median | $457.8M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Orasure Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.